Idexx Laboratories Asia Pacific — Total Revenue increased by 0.2% to $94.38M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.5%, from $81.73M to $94.38M. Over 4 years (FY 2021 to FY 2025), Asia Pacific — Total Revenue shows relatively stable performance with a 1.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market expansion or higher demand for veterinary diagnostics in the region, while a decrease may signal competitive pressure or economic headwinds in those specific markets.
This metric represents the total gross revenue generated from the sale of diagnostic products, veterinary equipment, and...
Comparable to regional revenue segments reported by other global life sciences or medical device companies, often benchmarked against regional GDP growth and veterinary market maturity.
idxx_segment_asia_pacific_total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $83.62M | $78.24M | $84.73M | $83.86M | $80.10M | $76.80M | $78.79M | $78.36M | $80.91M | $77.67M | $82.38M | $76.30M | $80.44M | $80.97M | $83.31M | $81.73M | $89.30M | $90.72M | $94.17M | $94.38M |
| QoQ Change | — | -6.4% | +8.3% | -1.0% | -4.5% | -4.1% | +2.6% | -0.5% | +3.2% | -4.0% | +6.1% | -7.4% | +5.4% | +0.7% | +2.9% | -1.9% | +9.3% | +1.6% | +3.8% | +0.2% |
| YoY Change | — | — | — | — | -4.2% | -1.8% | -7.0% | -6.6% | +1.0% | +1.1% | +4.5% | -2.6% | -0.6% | +4.3% | +1.1% | +7.1% | +11.0% | +12.0% | +13.0% | +15.5% |